Product Information
FLUOXETINE HCL 60 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3787 per EA under NDC 68180099706. Its NADAC has been published 334 times since Jul 3, 2019.
FDA first approved this application on Feb 8, 2019.
Strength
60 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180099706
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
FLUOXETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211632FDA Approved
2/8/2019
On Market Since
4/9/2019
Pharmacological Classes
Price Statistics
The NADAC for FLUOXETINE HCL 60 MG TABLET has been published 334 times since Jul 3, 2019, and over the history we have for it it has declined 92.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3787 per EA |
|---|---|
| All-time high | $5.2578 (Jul 10, 2019) |
| All-time low | $0.3198 (Nov 20, 2024) |
| 52-week high | $0.3787 |
| 52-week low | $0.3336 |
| Median price | $0.7428 |
| Average price | $1.1900 |
| Largest weekly change | -58.4% (Jul 22, 2020) |
| Weeks tracked | 334 |
| Tracking since | Jul 3, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+10.6%
3Y
-16.2%
5Y
-38.6%
All
-92.8%
Last surveyed Nov 19, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluoxetine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluoxetine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOXETINE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUOXETINE HCL 60 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.3787 per EA (NDC 68180099706), effective Nov 19, 2025.
How has the price of FLUOXETINE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUOXETINE HCL 60 MG TABLET has declined 92.8%. It has been tracked across 334 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for FLUOXETINE HCL 60 MG TABLET?
Since Jul 3, 2019, the NADAC for FLUOXETINE HCL 60 MG TABLET has ranged from a low of $0.3198 (Nov 20, 2024) to a high of $5.2578 (Jul 10, 2019), with a median of $0.7428 per EA.
Are there cheaper alternatives to FLUOXETINE HCL 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FLUOXETINE HCL 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOXETINE HCL 60 MG TABLET?
FLUOXETINE HCL 60 MG TABLET (NDC 68180099706) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.